Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Subcutaneous Drug Delivery Devices Market, by Region, 2018-2027 (USD Billion)
1.2.2. Subcutaneous Drug Delivery Devices Market, by Product, 2018-2027 (USD Billion)
1.2.3. Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Subcutaneous Drug Delivery Devices Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Subcutaneous Drug Delivery Devices Market Dynamics
3.1. Subcutaneous Drug Delivery Devices Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Subcutaneous Drug Delivery Devices Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Subcutaneous Drug Delivery Devices Market, by Product
5.1. Market Snapshot
5.2. Global Subcutaneous Drug Delivery Devices Market by Product, Performance - Potential Analysis
5.3. Global Subcutaneous Drug Delivery Devices Market Estimates & Forecasts by Product 2017-2027 (USD Billion)
5.4. Subcutaneous Drug Delivery Devices Market, Sub Segment Analysis
5.4.1. Prefilled Syringes
5.4.2. Pen Injectors
5.4.3. Auto Injectors
5.4.4. Wearable Injectors
5.4.5. Needle-Free Injectors
Chapter 6. Global Subcutaneous Drug Delivery Devices Market, by Distribution Channel
6.1. Market Snapshot
6.2. Global Subcutaneous Drug Delivery Devices Market by Distribution Channel, Performance - Potential Analysis
6.3. Global Subcutaneous Drug Delivery Devices Market Estimates & Forecasts by Distribution Channel 2017-2027 (USD Billion)
6.4. Subcutaneous Drug Delivery Devices Market, Sub Segment Analysis
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies
6.4.3. Online Pharmacies
Chapter 7. Global Subcutaneous Drug Delivery Devices Market, Regional Analysis
7.1. Subcutaneous Drug Delivery Devices Market, Regional Market Snapshot
7.2. North America Subcutaneous Drug Delivery Devices Market
7.2.1. U.S. Subcutaneous Drug Delivery Devices Market
7.2.1.1. Product breakdown estimates & forecasts, 2017-2027
7.2.1.2. Distribution Channel breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Subcutaneous Drug Delivery Devices Market
7.3. Europe Subcutaneous Drug Delivery Devices Market Snapshot
7.3.1. U.K. Subcutaneous Drug Delivery Devices Market
7.3.2. Germany Subcutaneous Drug Delivery Devices Market
7.3.3. France Subcutaneous Drug Delivery Devices Market
7.3.4. Spain Subcutaneous Drug Delivery Devices Market
7.3.5. Italy Subcutaneous Drug Delivery Devices Market
7.3.6. Rest of Europe Subcutaneous Drug Delivery Devices Market
7.4. Asia-Pacific Subcutaneous Drug Delivery Devices Market Snapshot
7.4.1. China Subcutaneous Drug Delivery Devices Market
7.4.2. India Subcutaneous Drug Delivery Devices Market
7.4.3. Japan Subcutaneous Drug Delivery Devices Market
7.4.4. Australia Subcutaneous Drug Delivery Devices Market
7.4.5. South Korea Subcutaneous Drug Delivery Devices Market
7.4.6. Rest of Asia Pacific Subcutaneous Drug Delivery Devices Market
7.5. Latin America Subcutaneous Drug Delivery Devices Market Snapshot
7.5.1. Brazil Subcutaneous Drug Delivery Devices Market
7.5.2. Mexico Subcutaneous Drug Delivery Devices Market
7.6. Rest of The World Subcutaneous Drug Delivery Devices Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Gerresheimer AG
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Medtronic plc
8.2.3. Ypsomed AG
8.2.4. Elcam Medical Group
8.2.5. Novo Nordisk A/S
8.2.6. Insulet Corporation
8.2.7. Becton, Dickinson, and Company
8.2.8. West Pharmaceutical Services, Inc.
8.2.9. PharmaJet, Inc.
8.2.10. Unilife Corporation
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption